baber/WOPTO huggingface dataset:
Patent CA-2439324-A1 (CA)
Title: Method for regulating an electrolysis cell
Inventor: VANVOREN CLAUDE
IPC: C25C3/20
Filed: 2002-02-27
Abstract: The invention relates to a method for regulating an electrolysis cell for the production of aluminium by reduction of aluminium dissolved in a melted cryolite bath and includes the addition, in the electrolyte bath, during predetermined time intervals p known as periods , of a determined quantity Q(p) of aluminium trifluoride (AlF¿3?) determined by the following ratio: Q(p)=Qint(p)-Qcl(p)+Qt(p), where Qint(p) is an integral (or auto-adaptive ) term representing the total real requirements of the cell in terms of AlF¿3? which is calculated from an average Qm(p) of the real intake of AlF¿3? during the last N periods, Qcl is a corrective term corresponding to the equivalent quantity of AlF¿3? contained in aluminium added to the cell during the period p, and Qt(p) is a corrective term which is a typically increasing function of the difference between the measured temperature of the bath T(p) and a predetermined set temperature. The inventive method enables efficient regulation of the acidity of an electrolysis cell to intensities of up to 500 kA for an electrolyte bath having an AlF¿3?content which is greater than 11 %.
Patent CA-2439503-A1 (CA)
Inventor: WEI GUANGWEN
IPC: A61P31/14
Filed: 2002-02-28
Abstract: The present invention relates to the use of recombination super compound interferon (rSIFN-co) as hepatitis B surface antigen and e antigen inhibitor, in which the space structure of said interferon protein has been changed.
Patent CA-2443170-A1 (CA)
Inventor: SCHUETZ EKKEHARD
IPC: C12Q1/6888
Filed: 2002-04-01
Abstract: Cette invention concerne des méthodes sensibles de dosage par hybridation d'acides nucléiques destinées à détecter des acides nucléiques cibles d'origine animale dans un prélèvement biologique, tel que des fluides acellulaires. Ces méthodes sont particulièrement utiles pour le diagnostic précoce de maladies animales, notamment des maladies chroniques.
Patent CA-2445431-A1 (CA)
Inventor: BRINDLE JOANNE TRACEY
IPC: A61B5/055
Filed: 2002-04-23
Abstract: Published without an Abstract
Patent CA-2446004-A1 (CA)
Inventor: BRANDON RICHARD BRUCE
IPC: G06F19/00
Filed: 2002-05-03
Abstract: A condition and ability of an animal to perform to its best ability may be determined by correlating gene expression with clinical and other data. The invention provides methods for assessing a performance animal's condition including the steps of collecting biological samples and clinical history, generating digital results on relative or absolute gene expression levels in the samples, transmitting the digital results via a communications network to a remote diagnostic server and associated database, comparing the results with information stored in the remote database and returning a report of the condition of the animal. A diagnostic system comprising a microarray, a microarray reader, a remote database for storing information from the reader, and a remote server receiving digital signals from the reader is also disclosed.
Patent CA-2447187-A1 (CA)
Inventor: KEKEZ MLADEN MARKO
IPC: H03K3/86
Filed: 2003-10-28
Abstract: A device for generating and radiating radio frequencies. The device includes a transmission line, a source, and a means for applying a voltage impulse to the transmission line from a low impedance source. A quarter-wave trap is added between the source and the transmission line to suppress the onset of a parasitic radiating mode. The quarter-wave trap also acts as an antenna to transmit the energy to the surrounding environment from the transmission line, which is behaving as an oscillatory circuit. The low impedance source is an electrically driven impulse generator. As a further modification, a second antenna can be attached to the free end of the transmission line to enable lower frequencies to be transmitted.
Patent CA-2448045-A1 (CA)
Inventor: ANTONOV ROUMEN
IPC: A61P17/06
Filed: 2002-05-23
Abstract: The invention concerns the use of antifungal agents, in particular those active on fungi of genus Candida, for preparing medicines for preventing or treating pathologies related to the presence in the human organism the following fungi: Entomocorticum sp., Stereum annosum, Phellinus igniarus,Peniophora pithya, Peniophora pieceae, Xilaria longipes, Rosellinia arcuata, Rosellinia necatrix, Multiclavula vernalis, Hericium coralloides, Hericium abietis, Hericium erinaceum, Hericium rivularis, Tricholoma terreum.
Patent CA-2449083-A1 (CA)
Inventor: KIPPIE DAVID P
IPC: C09K8/035
Filed: 2002-05-31
Abstract: The present invention relates to methods and compositions for increasing the effective temperature range for viscosified fluids, including particularly fluids that have been viscosified by the addition of a natural or a natural derivative polymer. In one embodiment, the present invention relates to a method for increasing the effective temperature range for a polymer-viscosified fluid used as a well fluid, which includes adding a miscible tertiary, secondary, and/or primary amine compound into a polymer solution. In another embodiment, the present invention relates to a thermally stable well fluid, which includes a polymer, a solvent, and a tertiary, secondary, and/or primaryamine miscible in the solvent.
Patent CA-2453116-A1 (CA)
Inventor: KONRAD WOLFGANG
IPC: G07B15/06
Filed: 2002-06-12
Abstract: The invention relates to a method for monitoring the regular operation of a charging device (BEV) for a vehicle (FAR) with a vehicle characteristic numb er (KEN). At least one given optical pattern/signal (MUS) is generated on the vehicle (FAR), which is characteristic for the operating state of the chargi ng device (BEV).
Patent CA-2454361-A1 (CA)
Title: Humanized antibodies
Inventor: KOHLSTAEDT LORI ALLISON
IPC: A61P31/04
Filed: 2002-07-19
Abstract: The invention provides humanized antibodies, for example, those that that bind ICAM-1, methods of use and methods of producing the antibodies. Antibodies include sequences having a VH and VL domain selected from HumA, HumB, HumC, HumD, HumE, HumF, HumG, HumH, HumI, Hum40 and Hum50.
Patent CA-2455223-A1 (CA)
Title: Crfr1 selective ligands
Inventor: RIVIER JEAN E F
IPC: A61P9/12
Filed: 2002-07-30
Abstract: CRF peptide analogs that bind to CRFR1 with an affinity far greater than they bind to CRFR2. These analogs exhibit CRF agonist activity.
Patent CA-2455765-A1 (CA)
Inventor: JANISCH DARREL R
IPC: B60R25/04
Filed: 2004-01-15
Abstract: Herein is disclosed a snowmobile configured to start in response to a remote-start signal. One embodiment of the invention includes a snowmobile outfitted with a remote starting system. The remote starting system, itself, includes a remote starting activation switch that transmits a radio frequency signal to a remote starter module to initiate starting of an engine within the snowmobile. The remote starter module receives the radio frequency signal from the remote starting activation switch and, in response to receiving the radio frequency signal, initiates closure of a switch interposed between a battery and a starter motor, thereby causing the starter motor to crank and start the engine of the snowmobile.
Patent CA-2457640-A1 (CA)
Inventor: TANAKA HAJIME
IPC: B62D5/24
Filed: 2004-02-13
Abstract: An elastic support assembly for an electric power steering apparatus in which a worm shaft is supported movably in a rotation axis direction through the elastic support assembly includes: a pair of first and second members relatively moving in the rotation axis direction according to a movement of the worm shaft; an elastic body provided between the first and second members in the rotation axis direction; and a cover which covers an outer periphery part of the elastic body from a radial direction of the worm shaft and is connected to the first member.
Patent CA-2458209-A1 (CA)
Title: Compositions comprising pectin and ascorbic acid
Inventor: CHEN CHYI-CHENG
IPC: A61K47/36
Filed: 2002-08-24
Abstract: Ascorbic acid compositions in the form of a powder and/or granules contain a s principal components L-ascorbic acid and/or a pharmaceutically acceptable sa lt thereof, and a high molecular (300 kDalton or higher) pectin. The compositio ns are compressible into tablets with improved mechanical strength and hardness .
Patent CA-2461417-A1 (CA)
Inventor: TOTZKE JUERGEN
IPC: H04L29/06
Filed: 2002-09-09
Abstract: L'invention concerne une unité de connexion de réseaux (NU) permettant d'obtenir un couplage à logique directe, basé sur un protocole de transport, de plusieurs réseaux de communication VoIP (KN1, KN2) avec différents protocoles de commande de liaison (SP1, SP2) liés au protocole de transport par paquets (IP). Pour cela, l'unité de connexion de réseaux (NU) comprend, pour chacun des réseaux de communication VoIP (KN1, KN2) à coupler, une interface de données (D1, D2) basée sur un protocole de transport, une interface de signalisation (S1, S2) basée sur un protocole de commande de liaison, ainsi qu'un convertisseur (SIWU) pour la conversion entre les différents protocoles de commande de liaison (SP1, SP2).
Patent CA-2461892-A1 (CA)
Title: Intelligent service management system
Inventor: CURTIS DAVID C
IPC: G06Q10/10
Filed: 2002-09-26
Abstract: A system (700) manages the operations of an integrated communications provider. One aspect of the system is a work flow engine. The work flow engine decomposes the service model into sub-model components based upon whether crossing of plural networks is appropriate to provide requested telecommunication services and which service providers are available to provide service consistent with the location of the customer. The work flow engine also creates a telecommunications design (713) from the sub-model components based on order rules of the service providers. The system automatically retrieves customer service records (703) and preparing sales proposals based on those records. The system includes a gateway to incumbent local exchange carriers and trading partner (715) service providers. The system incorporates features that automate comparisons between existing services and proposed services, optimizing on-net and off-net services, creation of cutover reports, issuance of service requests to local exchange carriers and trading partners (715), and alarming of failures of confirmations.
Patent CA-2462449-A1 (CA)
Inventor: OLSON KEITH E
IPC: C11D1/72
Filed: 2002-11-26
Abstract: The present invention relates to methods and compositions for cleaning or sanitizing carpet or upholstery. Powder, other solid, or agglomerate compositions include active oxygen compound, surfactant, and builder. The methods of cleaning or sanitizing carpet or upholstery include applying to the carpet or upholstery such a solid (e.g., powder) or agglomerate composition or a use solution of one of these compositions.
Patent CA-2463009-A1 (CA)
Title: Removable light assembly of pre-defined shape for a weapon
Inventor: MILLER RODNEY
IPC: F21K9/00
Filed: 2004-04-01
Abstract: A light assembly having a pre-defined shape is provided to be removably attached to a guide provided on a weapon. The light assembly comprises a housing provided with a reflector having a lamp at one end thereof and batteries for powering the lamp through a switch. The housing has a pair of lateral members which are movable between a retracted position and an extended position so that, when the members are in the retracted position, the light assembly has the above-mentioned pre-defined shape and when the members are in the extended position, they are adapted to engage the guide. Means for preventing the longitudinal movement of the light assembly on the guide are also provided with the light assembly. The light assembly can thus be easily mounted and used as an aiming device with a weapon or be readily used as a separate and independent entity.
Patent CA-2464489-A1 (CA)
Inventor: MALLOY CLAUDE SR
IPC: A47K11/06
Filed: 2004-04-08
Abstract: Our translucent plastic urinal has a new improved cover lid w/cup attached inside. Also, this lightweight plastic cup has holes to help release the new fresh clean scented material contain inside the cup. Furthermore, our urinal's new improved handle, comes with an exact small-size plastic bottle with hose. Now, the user can squeeze the new cleaning liquid from the bottle handle thru the hose into the water-waste compartment of the urinal.
Patent CA-2465038-A1 (CA)
Inventor: ACH ERNST
IPC: B66B11/04
Filed: 2002-11-22
Abstract: L'invention concerne un système d'ascenseur comportant au moins un moteur d'entraînement (2) doté d'au moins une poulie motrice (16), une cabine (3), au moins un contrepoids (8) et au moins un dispositif support flexible. La cabine (3) et le contrepoids sont chacun dotés d'au moins un rouleau porteur (7, 11). Le dispositif support (18) forme, avec la poulie motrice (16) et les rouleaux porteurs (7, 11), un système de suspension 2:1 pour la cabine (3) et le contrepoids (8). Selon l'invention, le système de suspension 2:1 est disposé de telle façon que le dispositif support (18)est toujours déplacé dans le même sens par la poulie motrice (16), les rouleaux porteurs (7, 11) et les poulies de renvoi (17) éventuelles.
Patent CA-2465675-A1 (CA)
Title: Improved particulate compositions for pulmonary delivery
Inventor: EDWARDS DAVID A
IPC: A61L9/04
Filed: 2002-11-20
Abstract: This invention concerns an improved particulate composition for delivering a drug to the pulmonary system. Applicants disclose a method of identifying an optimal form of aerodynamically light particles which are highly dispersible.  The particles of the instant invention are made by creating hollow, spherical drug particles (i.e., progenitor particles) that collapse in the process of particle formation, leading to wrinkled, thin-walled drug particles of very low envelope density. Additionally, applicants have found that such particles are especially optimal for inhaled aerosols when the surface area parameter (.SIGMA.) is greater than 2, optimally greater than 3.
Patent CA-2466884-A1 (CA)
Inventor: SUOMI ERIC W
IPC: H05B37/02
Filed: 2003-01-23
Abstract: L'invention concerne l'extraction d'une série d'impulsions d'éclairage destinées à un ou plusieurs accessoire(s) de luminaire (26), ces impulsions étant fournies par un gradateur (28) à angle de phase. Une alimentation C.C. (44) est connectée à la sortie (38, 40) du gradateur (28) afin de développer et de stocker une alimentation d'accessoires en courant C.C. Un contrôleur de lampe (48) est connecté à la sortie (38, 40) du gradateur (28) afin de transférer la puissance des impulsions d'éclairage à ladite lampe (24). Ledit contrôleur de lampe (48) possède une caractéristique de transfert d'impulsions variables permettant d'alimenter la lampe sans dégrader sa performance, ladite dégradation pouvant être entraînée par des variations d'alimentation d'accessoires. La caractéristique de transfert d'impulsions variables peut être mise en oeuvre au moyen d'un dispositif de commutation (76) qui interrompt ou bloque des partie sélectionnées d'impulsions d'éclairage. Cette caractéristique de transfert d'impulsions maintient constante une brillance de lampe apparente indépendamment des exigences d'alimentation d'accessoires. A l'état arrêté ou préchauffé, un transfert d'alimentation à la lampe (24) est réduit afin d'empêcher une émission de faisceau visible lumineux. A l'état de brillance maximum, les impulsions d'éclairage ne sont pratiquement pas modifiées par le contrôleur de lampe (48).
Patent CA-2467876-A1 (CA)
Title: Architecture for connecting a remote client to a local client desktop
Inventor: DAUGHERTY TRACY M
IPC: G06F21/33
Filed: 2004-05-20
Abstract: Architecture for generating and maintaining a terminal services connection from all external client to an internal intranet client behind a firewall and/or router. The external user is first authenticated after which the external client is passed to a remote user portal. A listing of available internal computers is presented to the external client user, the selection of one that initiates an intranet server to create a listening socket thereon, and a socket on the selected internal client. The server creates a thread that manages the terminal services connection between the external client and the internal client by listening for traffic and forwarding the traffic between the ports.
Patent CA-2468546-A1 (CA)
Inventor: GOLDOWSKY MICHAEL P
IPC: F04D13/06
Filed: 2004-05-27
Abstract: The ultimate in suplicity and reliability, an axial-flow blood pump is supported by an all passive contact-free hybrid bearing suspension that can measure differential pump pressure. The preferred suspension consists of a radial hydrodynamic journal bearing with axial magnetic thrust bearings. The thrust bearing consists of repulsion magnet pairs positioned at each end of the rotor. This holds bidirectional loads with a stable restoring force (negative axial stiffness). Rotor axial position shifts with load and is monitored with a position sensor to inherently provide pump differential pressure (which may be used to physiologically control pump flow rate). The hydrodynamic radial and "smart" axial magnet thrust bearings use large gaps to eliminate hemolysis and are actively washed out under pressure with fresh blood to eliminate thrombosis.
Patent CA-2468574-A1 (CA)
Title: Method and apparatus for determining the log-likelihood ratio with precoding
Inventor: GUPTA ALOK
IPC: H04L25/03
Filed: 2002-11-27
Abstract: An apparatus and method for recovering data transmitted in a wireless communication system is claim. A plurality of signal points, the signal poin t comprising a plurality of modulation symbols from a plurality of coded bits, is received (604). A first subset of signal points for which a bit is equal to a first value and a second subset of signal points for which the bit is equa l to a second value is determined (608). The first and second subset are signa l points from an expanded signal constelation. The probability of that the bit is equal to the first value or the second value is determined as a function of the received signal point (612). A soft decision symbol may then be determined, based on the probability that the bit is equal to the first valu e or the second value. The soft decision symbols may be represented as log likelihood ratios (616).
Patent CA-2469151-A1 (CA)
Inventor: GILLIES STEPHEN D
IPC: C07K19/00
Filed: 2002-12-04
Abstract: L'invention concerne des protéines de fusion de cytokine à indice thérapeutique augmenté et des méthodes permettant d'augmenter l'indice thérapeutique de ces protéines de fusion. Lesdites protéines de fusion peuvent se lier à plus d'un type de récepteur de cytokine exprimé sur des cellules et à plus d'un type de cellule. Elles peuvent également présenter une demi-vie circulante plus longue dans le corps d'un patient que la cytokine naturelle correspondante.
Patent CA-2471926-A1 (CA)
Inventor: LUCAST DONALD H
IPC: A61L15/58
Filed: 2002-12-05
Abstract: A pressure sensitive adhesive composition is provided that includes a pressu re sensitive adhesive polymer. The polymer includes: at least one copolymerized monoethylenically unsaturated (meth)acrylic acid ester monomer, wherein the (meth)acrylic acid ester monomer, when homopolymerized, has a Tg of less tha n about 25 ~C; at least one copolymerized monoethylenically unsaturated reinforcing monomer, wherein the reinforcing monomer, when homopolymerized, has a Tg of at least about 25 ~C; covalently bonded quarternary ammonium functionality; and, optionally, at least one copolymerized monoethylenically unsaturated poly(alkylene oxide) monomer. The composition optionally further includes at least one nonreactive poly(alkylene oxide) polymer and/or at lea st one antimicrobial agent.
Patent CA-2472328-A1 (CA)
Inventor: GOKCE ISA
IPC: C07K19/00
Filed: 2003-01-10
Abstract: The present invention relates to fusion proteins (fusion polypeptides), particularly for use in expression and/or purification systems. The present inventors have found that the To1AIII domain has remarkable properties which are of particular use as a fusion protein partner to achieve high levels of expression in a host cell. In one aspect of the invention, a To1AIII domain or a functional homologue, fragment, or derivative thereof is located towards the N-terminus of the fusion polypeptide and a non-To1A polypeptide is located towards the C-terminus of the fusion polypeptide.
Patent CA-2473465-A1 (CA)
Title: Apparatus for low coherence ranging
Inventor: TEARNEY GUILLERMO J
IPC: G01N21/17
Filed: 2003-01-10
Abstract: An apparatus for performing low coherence ranging of a sample with high transverse resolution and large depth of focus, comprising an optical ranging system comprising a light source, a means for directing light from the light source to the sample, a means for directing reflected light from the sample to a detector, at least one detector, a means for processing light data received by the detector and which generates an image; and an optical element having a transverse resolution defined as ..DELTA.ris less than or equal to about 5~m, and a depth of focus .DELTA.z of at least about 50 ~m.
Patent CA-2476015-A1 (CA)
Title: Installation et procede de production intermittente et continue de stratifies a l'aide d'une presse a plusieurs etages
Inventor: STABILE ALDO
IPC: B29L9/00
Filed: 2002-03-01
Abstract: L'invention concerne une installation (10) et un procédé de production intermittente et continue de stratifiés F, G au moyen d'une bande composite (162) obtenue à partir de bandes de divers composants (80, 90, 120-127) du stratifié. Cette production est effectuée dans une presse à plusieurs étages (11) qui présente un cycle de production dont tous les étages, de durée égale, sont répartis entre les divers étages 1 à 5. Dans chaque étage, une phase est effectuée ultérieurement à celle effectuée dans l'étage précédent par un mouvement de la bande composite (162), à la fin de chaque phase, d'un étage à l'autre, le temps de production pour chaque stratifié F, G correspondant au temps pris par le cycle de production divisé par le nombre d'étages 1-5.
Patent CA-2478986-A1 (CA)
Inventor: THOMSON JAMES A
IPC: C12Q1/68
Filed: 2003-03-14
Abstract: L'invention concerne un procédé d'identification des facteurs génétiques responsables de la différenciation cellulaire basée sur le clonage d'expression. Pour déterminer quel facteur génétique conduit à la différenciation d'une cellule à partir d'un type de cellule de départ à un type de cellule cible, une banque d'ADNc est obtenue, encapsidée dans un vecteur d'expression et transformée en cellules du type cellulaire de départ. Le vecteur d'expression comprend également, de préférence, un système de gène marqueur sous la commande d'un promoteur à spécificité tissulaire pouvant être utilisé dans le type de tissu du type cellulaire cible. Les cellules transformées sont ensuite mises en culture jusqu'à ce que la différenciation cellulaire commence, ensuite la culture est criblée ou soumise à sélection afin d'identifier les cellules subissant une différenciation vers le type cellulaire cible. Par l'examen de la pièce rapportée d'ADNc dans les cellules différenciées, le facteur génétique responsable du processus de différenciation peut être identifié.